CSIMarket
 

Staar Surgical Co  (NASDAQ: STAA)

Staar Surgical Co's

Competitiveness




 

STAA Sales vs. its Competitors Q2 2026



Comparing the current results to its competitors, Staar Surgical Co reported Revenue increase in the 2 quarter 2026 by 111.04 % year on year.
The sales growth was above Staar Surgical Co's competitors' average revenue growth of 7.46 %, achieved in the same quarter.

List of STAA Competitors

With a net margin of 8.61 % Staar Surgical Co reported lower profitability than its competitors.

More on STAA Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Staar Surgical Co achieved net profit of $8.06 millions compared to a net loss of $-16.81 millions recorded in the same quarter a year ago.

<<  STAA Stock Performance Comparisons



  

Overall company Market Share Q2 2026

Due to outstanding performance in Overall company, revenue grew by 111.04 % Staar Surgical Co improved its market share, to approximately 0.27 %.




<<  More on STAA Market Share.
 
*Market share is calculated based on total revenue.

  News about Staar Surgical Co Contracts

Revamping Vision Correction: STAAR Surgical and IQ Laser Vision Join Forces to Unlock New Possibilities

May 7, 2024
STAAR Surgical and IQ Laser Vision Enter Strategic Agreement for Enhanced Vision SolutionsLake Forest, Calif. - STAAR Surgical Company (NASDAQ: STAA), a renowned pioneer in the development, manufacturing, and marketing of the EVO family of Implantable Collamer Lenses (EVO ICL) for myopia, astigmatism, and presbyopia, has announced a significant milestone in its U.S. Highway 93 go-to-market program. The company has entered into a strategic agreement with IQ Laser Vision, a trusted leader in providing clear vision across California and Texas, and a prominent EVO ICL practice in North America.The agreement between STAAR Surgical and IQ Laser Vision aims to improve the accessibility and affordability of the adva...





Publicly Traded Peers of Staar Surgical Co




Alcon inc
Share Performance



-8.48%
This Year



Alcon inc
Profile

Alcon Inc's business model revolves around providing advanced eye care products and services, including pharmaceuticals, surgical equipment, and vision care solutions.

More about Alcon inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 35,240.124 mill. $ 12,997.000 mill. $ 1,156.000 mill.


Bausch and Lomb Corp
Share Performance



+5.13%
Over The Past 5 Days



Bausch and Lomb Corp
Profile

Bausch and Lomb Corp's business model revolves around developing and manufacturing eye health products and vision care solutions.

More about Bausch and Lomb Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 6,438.513 mill. $ 5,324.000 mill. $ -163.000 mill.


Boston Scientific Corporation
Share Performance



-55.70%
One Year



Boston Scientific Corporation
Profile

Boston Scientific Corporations business model centers on creating innovative medical devices for diverse specialties, aimed at addressing unmet medical needs and enhancing patient outcomes. The company sells its products to healthcare professionals and hospitals globally, supported by robust sales and distribution networks. It prioritizes research and development to continually introduce new technologies and solutions.

More about Boston Scientific Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 71,005.025 mill. $ 20,616.000 mill. $ 3,559.000 mill.


The Cooper Companies Inc
Share Performance



-13.65%
This Year



The Cooper Companies Inc
Profile

The Cooper Companies Inc is a global medical device firm focused on manufacturing and distributing contact lenses and womens healthcare products. Its business model emphasizes innovation, strong distribution, strategic acquisitions, and partnerships to enhance market presence, targeting the specific needs of customers in eye care and womens health. Through research and development, they aim to improve customer lives while maximizing shareholder value.

More about The Cooper Companies Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 13,657.800 mill. $ 4,230.400 mill. $ 235.800 mill.


National Vision Holdings Inc
Share Performance



-26.92%
One Year



National Vision Holdings Inc
Profile

National Vision Holdings Inc is a leading retailer of eyewear and optical products in the United States. The company operates a vertically integrated business model, which involves manufacturing, marketing, and distributing a wide range of eyewear products through its branded retail stores and third-party retail locations. National Vision Holdings Inc focuses on offering affordable and accessible vision care solutions to customers by leveraging its supply chain and retail network capabilities.

More about National Vision Holdings Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,383.045 mill. $ 2,033.426 mill. $ 50.286 mill.

11 more competitors available

Sign in to see all competitors

Sources: Staar Surgical Co’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Staar Surgical Co versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.